Applied Therapeutics APLT

$ 0.88 -13.73%

Quarterly report 2024-Q3
added 11-07-2024

Applied Therapeutics Financial Statements 2011-2024 | APLT

Annual Financial Statements Applied Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	541 M	35.2 M	78.8 M	470 M	682 M	-	-	-	-	-	-	-	-
Shares	84.2 M	37.8 M	25.6 M	22.4 M	12.8 M	-	-	-	-	-	-	-	-
Historical Prices	6.42	0.93	3.08	20.9	52.5	-	-	-	-	-	-	-	-
Net Income	-120 M	-82.5 M	-106 M	-94 M	-45.5 M	-16.5 M	-4.28 M	-	-	-	-	-	-
Revenue	9.99 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-64.5 M	-83 M	-106 M	-94.5 M	-45.6 M	-13.5 M	-	-	-	-	-	-	-
Interest Expense	-27 K	-177 K	-521 K	-54 K	-24 K	-1.14 M	-	-	-	-	-	-	-
EBITDA	-64.5 M	-83 M	-106 M	-94.1 M	-45.6 M	-13.3 M	-4.28 M	-	-	-	-	-	-
Operating Expenses	74.5 M	83 M	106 M	94.5 M	45.6 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	20.6 M	27.3 M	43 M	32.7 M	13.2 M	2.05 M	582 K	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Applied Therapeutics

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	144 M	144 M	84.9 M	90.7 M	79 M	56.4 M	48.1 M	48 M	26.9 M	26.2 M	26.2 M	26.2 M	26.1 M	24.1 M	22.5 M	22.4 M	22.1 M	20.8 M	18.5 M	17.1 M	13.9 M	5.51 M	5.51 M	5.5 M	5.46 M	5.46 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-68.6 M	2.9 M	-	-42.4 M	-29.6 M	-10.1 M	-	-19.1 M	-25.9 M	-23.1 M	-	-28.4 M	-25.8 M	-24.2 M	-	-29.8 M	-28.1 M	-12.4 M	-	-10.7 M	-8.44 M	-45.5 M	-	-4.28 M	-3.18 M	-2.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	122 K	144 K	-	-	-	10.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-29.7 M	-20.4 M	-	-15.5 M	-17.2 M	-10.9 M	-	-19.4 M	-21.5 M	-23.1 M	-	-28.4 M	-25.9 M	-24.2 M	-	-30 M	-28.3 M	-12.5 M	-	-10.7 M	-8.44 M	-8.73 M	-	-3.32 M	-2.34 M	-1.87 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-21 K	-34 K	-	10 K	-5 K	31 K	-	-8 K	-90 K	-96 K	-	-64 K	-122 K	-56 K	-	-10 K	38 K	-24 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-29.7 M	-20.4 M	-	-15.5 M	-17.2 M	-10.9 M	-	-19.4 M	-21.5 M	-23.1 M	-	-28.4 M	-25.9 M	-24.2 M	-	-30 M	-28.3 M	-12.5 M	-	-10.7 M	-8.44 M	-8.73 M	-	-3.32 M	-2.34 M	-1.87 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	29.9 M	20.6 M	-	15.5 M	17.2 M	21.5 M	-	19.4 M	21.5 M	23.1 M	-	28.4 M	25.9 M	24.2 M	-	30 M	28.3 M	12.5 M	-	10.7 M	8.44 M	8.73 M	-	3.32 M	2.34 M	1.87 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	15 M	10.6 M	-	4.71 M	5.29 M	5.58 M	-	6.24 M	6.12 M	8.07 M	-	10.8 M	11.1 M	9.75 M	-	10 M	7.52 M	5.2 M	-	3.29 M	4.18 M	1.86 M	-	598 K	400 K	420 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency